Optimize first
Many tools jump to allocation changes before the portfolio problem is visible.
Portfolio MRI
Investment Decision Room
Diagnosis-first portfolio intelligence
Portfolio MRI turns current holdings into stress-tested evidence, then tests one bounded candidate path only after the problem is named.
Evidence first
Portfolio MRI slows the moment down: current holdings become evidence, stress behavior becomes visible, and the candidate path only appears after the problem is named.
Many tools jump to allocation changes before the portfolio problem is visible.
Risk often appears as a score, not as a pressure path with contributors.
The reasoning chain between holdings, evidence, test path, and verdict gets fragmented.
Canonical flow
01
Enter current holdings, weights, currency, and cash as the evidence source.
02
Read concentration, exposure, risk contribution, and weakness signals first.
03
Replay pressure scenarios and see which exposures drive losses.
04
Layer investor context beside the portfolio evidence.
05
Compare the current portfolio with one bounded test path.
System map
Portfolio MRI keeps the same review context moving forward: current portfolio, stress behavior, client fit context, candidate test, comparison, and verdict.
Current holdings become the primary evidence source.
Loss paths, helped/hurt contributors, and hedge gaps.
A diagnosis that names the portfolio problem clearly.
One bounded test path, tied to the same review.
What improves, worsens, stays neutral, or remains unclear.
A grounded trade-off readout with evidence and limits.
Product boundaries
Current first
The existing portfolio stays the subject.
Evidence first
The portfolio problem is visible before a path is tested.
One path
The launchpad keeps the comparison readable.
Same run
Screens follow the same review lineage.
Ready
Sign in, answer the short setup questions, and enter the current portfolio. The first output is diagnosis: exposure, stress behavior, and the problem worth testing.
Enter PlatformPortfolio MRI provides non-binding diagnostic decision support. It does not provide investment advice, suitability approval, or trade instructions.